Traits that allow cancer cells to escape the body’s natural defence system and develop into tumours are actually a good indicator to a patient’s survival prognosis, according to ¹ú²ú̽»¨ researchers.
Australia’s response to the COVID pandemic has been a spectacular success, but has come at significant economic and broader health costs. To avoid another surge in case numbers, it is crucial that we plan for the coming months as we head into 2021.
Actual re-infection that has been confirmed with genetic sequencing has now been reported in a few rare cases worldwide, indicating that it is indeed possible.
How hopeful should Australians and New Zealanders be about COVID-19 vaccines becoming available in 2021? And what do we need to learn from 2020 and this pandemic as we speed towards the new year?
Locally made coronavirus proteins produced in a state-of-the-art laboratory in Brisbane are proving highly useful in a sophisticated blood test for COVID-19.
Can we really expect our lives to go back to normal in a post-vaccine world? Professor Ian Frazer and Dr Kirsty Short are back to answer the COVID-19 questions on all of our minds.
New research born out of collaborations with virologists and neuroscience here at QBI has shown that coronavirus has co-opted a clever entry mechanism to get into cells - including neurons.
An international team has found a way to potentially prevent the novel coronavirus from infecting cells, as well as clues as to why it is more infectious than similar viruses.
Federal funding will help a team of researchers determine how long immunity lasts in people who’ve recovered from COVID-19, critical information as the world waits for a vaccine.